“Biotech & Life Science”
Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies.
G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, is expanding its search for new anti-cancer weapons by launching three clinical trials targeting breast cancer patients.
A review of securities filings for December finds that it was a busy month across North Carolina with a wide variety of companies seeking investment capital.
Laboratory Corporation of America says it will add the outreach laboratories of Mount Sinai Health System to its network of lab services network.
Viamet Pharmaceuticals has reported positive results from clinical trials of its lead product candidate for the treatment of two common fungal infections.
International Resources Group, a provider of services to the U.S. Agency for International Development and with contracts around the world, is now part of RTP-based RTI International.
RTP-based BioCryst Pharmaceuticals has received approval to sell its influenza treatment in Canada. It's now available in five countries.
Here's a look back at technology, life science and other related news as reported in WRAL TechWire over this past week, part two.
Here's a look back at technology, life science and other related news as reported in WRAL TechWire for this past week, part one.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
GeneCentric CEO Myla Lai-Goldman, M.D.
Durham-based Metabolon strikes a deal with an Israeli company to utilize its metabolomics technology as a possible means of improving treatment for various inflammatory diseases.
Med device startup Bardy Diagnostics says it has closed on a "significant round of growth capital" from several investors. Among them is Durham-based Square 1 Bank.
Amid continuing rumors about an IPO, Avadim Technologies has raised another $250,000. In other SEC filing news, a Winston-Salem biotech looks to raise money and the founder of CommScope sells $10 million in shares.
Cruise That Knows You
Cohera Medical, a medical device startup backed by $50 million from private equity giant KKR which recently relocated to Raleigh, has launched a clinical trial of a proposed surgical sealant product.
Updated January 3
Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of Dec. 19-25, part one.
Updated January 3
Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of Dec. 19-25, part two.